As of 2025-06-02, the Intrinsic Value of Odonate Therapeutics Inc (ODT) is - USD. This ODT valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.12 USD, the upside of Odonate Therapeutics Inc is -100.00%.
Based on its market price of 1.12 USD and our intrinsic valuation, Odonate Therapeutics Inc (ODT) is overvalued by 100.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | - - - | - | -100.00% |
| P/E | (48.95) - (47.15) | (48.07) | -4391.6% |
| DDM - Stable | (19.01) - (53.56) | (36.29) | -3340.1% |
| DDM - Multi | (21.56) - (47.83) | (29.79) | -2759.7% |
| Market Cap (mil) | 43.11 |
| Beta | 0.47 |
| Outstanding shares (mil) | 38.49 |
| Enterprise Value (mil) | -51.92 |
| Market risk premium | 4.24% |
| Cost of Equity | 11.11% |
| Cost of Debt | 5.00% |
| WACC | 7.38% |